Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Hider

Showing results (161-170 of 176) with videos related to

Pageof 18
Sort By:
European Journal of Clinical Investigation|March 12, 2002
Nontransferrin-bound iron in the plasma of haemodialysis patients after intravenous iron saccharate infusionM P Kooistra, S Kersting, I Gosriwatana, et al.
European Journal of Clinical Investigation|March 12, 2002
Human immunodeficiency virus type 1 replication inhibition by the bidentate iron chelators CP502 and CP511 is caused by proliferation inhibition and the onset of apoptosisN A Georgiou, T van der Bruggen, M Oudshoorn, et al.
Annals of the New York Academy of Sciences|January 1, 1990
New orally effective iron chelators. Animal studiesC Hershko, G Link, A Pinson, et al.
The Journal of Biological Chemistry|October 17, 2001
Structure-function investigation of the interaction of 1- and 2-substituted 3-hydroxypyridin-4-ones with 5-lipoxygenase and ribonucleotide reductaseR Kayyali, J B Porter, Z D Liu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1992
Urinary metabolic profiles in human and rat of 1,2-dimethyl- and 1,2-diethyl-substituted 3-hydroxypyridin-4-onesS Singh, R O Epemolu, P S Dobbin, et al.
Redox Report : Communications in Free Radical Research|July 14, 2016
Mechanisms of antioxidant activities of quercetin and catechinG Paganga, H Al-Hashim, H Khodr, et al.
Journal of Pharmaceutical Sciences|February 25, 2000
Use of alveolar cell monolayers of varying electrical resistance to measure pulmonary peptide transportA N Dodoo, S S Bansal, D J Barlow, et al.
Pharmaceutical Research|March 14, 2000
Systematic investigations of the influence of molecular structure on the transport of peptides across cultured alveolar cell monolayersA N Dodoo, S Bansal, D J Barlow, et al.
The British Journal of Ophthalmology|January 1, 1989
Ocular toxicity of desferrioxamine--an example of copper promoted auto-oxidative damage?H Pall, D R Blake, P Winyard, et al.
Journal of Inorganic Biochemistry|August 15, 1992
The antimalarial effect of iron chelators: studies in animal models and in humans with mild falciparum malariaC Hershko, V R Gordeuk, P E Thuma, et al.
Pageof 18

Showing results (161-170 of 176) with videos related to

Sort By:
Pageof 18
European Journal of Clinical Investigation|March 12, 2002
Nontransferrin-bound iron in the plasma of haemodialysis patients after intravenous iron saccharate infusionM P Kooistra, S Kersting, I Gosriwatana, et al.
European Journal of Clinical Investigation|March 12, 2002
Human immunodeficiency virus type 1 replication inhibition by the bidentate iron chelators CP502 and CP511 is caused by proliferation inhibition and the onset of apoptosisN A Georgiou, T van der Bruggen, M Oudshoorn, et al.
Annals of the New York Academy of Sciences|January 1, 1990
New orally effective iron chelators. Animal studiesC Hershko, G Link, A Pinson, et al.
The Journal of Biological Chemistry|October 17, 2001
Structure-function investigation of the interaction of 1- and 2-substituted 3-hydroxypyridin-4-ones with 5-lipoxygenase and ribonucleotide reductaseR Kayyali, J B Porter, Z D Liu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1992
Urinary metabolic profiles in human and rat of 1,2-dimethyl- and 1,2-diethyl-substituted 3-hydroxypyridin-4-onesS Singh, R O Epemolu, P S Dobbin, et al.
Redox Report : Communications in Free Radical Research|July 14, 2016
Mechanisms of antioxidant activities of quercetin and catechinG Paganga, H Al-Hashim, H Khodr, et al.
Journal of Pharmaceutical Sciences|February 25, 2000
Use of alveolar cell monolayers of varying electrical resistance to measure pulmonary peptide transportA N Dodoo, S S Bansal, D J Barlow, et al.
Pharmaceutical Research|March 14, 2000
Systematic investigations of the influence of molecular structure on the transport of peptides across cultured alveolar cell monolayersA N Dodoo, S Bansal, D J Barlow, et al.
The British Journal of Ophthalmology|January 1, 1989
Ocular toxicity of desferrioxamine--an example of copper promoted auto-oxidative damage?H Pall, D R Blake, P Winyard, et al.
Journal of Inorganic Biochemistry|August 15, 1992
The antimalarial effect of iron chelators: studies in animal models and in humans with mild falciparum malariaC Hershko, V R Gordeuk, P E Thuma, et al.
Pageof 18